Live Breaking News & Updates on Rosemary Carella

John C. Martin, 69, Dies; Led Drugmaker in Breakthroughs
A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C.
John C. Martin in 2006 with a bottle of Truvada, a groundbreaking treatment for H.I.V. made by his company, Gilead Sciences, in the Bay Area. Credit.Paul Sakuma/Associated Press
April 27, 2021, 6:43 p.m. ET
John C. Martin, who became a billionaire by developing and marketing a daily single-dose pill that transformed H.I.V. into a manageable disease and who popularized another drug that cures hepatitis C, died on March 30 in Palo Alto, Calif. He was 69. ....

Purdue University , United States , Palo Alto , Santa Clara County , Foster City , Golden Gate University , San Francisco , John Milligan , Bristol Myers Squibb Sustiva , Johnc Martin , Tellis Alexander Martin , Bristol Myers Squibb , Rosemary Carella , John Charles Martin , International Society For Antiviral Research , Johnc Martin Foundation , Gilead Sciences , Human Services , Syntex Corporation , Healthcare Foundation , Noah Berger Associated , Department Of Health , University Of Chicago , Old Palo Alto , Hoffman La Roche , Associated Press ,